Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer

OBJECTIVE: Nanosomal docetaxel lipid suspension (NDLS) is a novel formulation developed to overcome toxicity issues caused by excipients (polysorbate 80 and ethanol) present in commercially available docetaxel formulation. We conducted a prospective, observational study to compare the outcomes of na...

Descripción completa

Detalles Bibliográficos
Autores principales: Badiginchala, Revathi, Dattatreya, Palanki Satya, Suresh, Attili Venkata Satya, Nirni, Sharanabasappa Somanath, Andra, Vindhya Vasini, Bunger, Deepak, Chaturvedi, Alok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075221/
https://www.ncbi.nlm.nih.gov/pubmed/37033671
http://dx.doi.org/10.2147/OTT.S400824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075221/
https://www.ncbi.nlm.nih.gov/pubmed/37033671
http://dx.doi.org/10.2147/OTT.S400824

Ejemplares similares